Imiquimod: Potential risk of an immunostimulant
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-0960.2004.00060.x/fullpdf
Reference11 articles.
1. Topical Imiquimod
2. Topical immunomodulators—progress towards treating inflammation, infection, and cancer
3. Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
4. Editorial
5. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biological applications of imiquimod analogues: An update (Review);World Academy of Sciences Journal;2023-06-30
2. Topical Therapies for Nonmelanoma Skin Cancers;Skin Cancer Management;2021
3. Management of keratinocyte carcinoma - Special considerations in the elderly;International Journal of Women's Dermatology;2019-09
4. The role of the skin microbiome in atopic dermatitis: a systematic review;British Journal of Dermatology;2017-11
5. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients;British Journal of Dermatology;2017-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3